Published in Eur Respir J on November 01, 2002
Matrix metalloproteinases in destructive pulmonary pathology. Thorax (2005) 2.06
Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A (2006) 1.37
Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol (2006) 1.32
Macrophage heterogeneity in respiratory diseases. Mediators Inflamm (2013) 1.20
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 1.02
Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respir Res (2005) 1.00
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Ann Thorac Med (2013) 0.94
Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. J Biol Chem (2011) 0.93
Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol (2015) 0.92
The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis. Med Sci Monit (2011) 0.92
The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J (2011) 0.91
MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. PLoS One (2012) 0.89
Interfering with extracellular matrix degradation to blunt inflammation. Curr Opin Pharmacol (2008) 0.87
Sarcoidosis: Immunopathogenesis and Immunological Markers. Int J Chronic Dis (2013) 0.85
An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition. Lung India (2011) 0.81
Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis. Clin Exp Immunol (2009) 0.81
Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan. PLoS One (2013) 0.81
Associations of MMP1, MMP2 and MMP3 Genes Polymorphism with Coal Workers' Pneumoconiosis in Chinese Han Population. Int J Environ Res Public Health (2015) 0.81
Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol (2009) 0.81
Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis. PLoS One (2014) 0.79
Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis. Am J Physiol Lung Cell Mol Physiol (2016) 0.78
Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung (2014) 0.78
TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis. Clin Mol Allergy (2015) 0.76
Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis. PLoS One (2016) 0.75
Evaluation of the use and usefulness of telephone consultations in one general practice. Br J Gen Pract (1992) 5.08
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Cancer in the offspring of radiation workers: a record linkage study. BMJ (1997) 3.13
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res (1998) 3.01
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
The accuracy of selective magnetic resonance imaging compared with the findings of arthroscopy of the knee. J Bone Joint Surg Am (1988) 2.08
Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol (1999) 2.08
Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06
The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res (1998) 2.01
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Phosphorylation of subunit proteins of intermediate filaments from chicken muscle and nonmuscle cells. Proc Natl Acad Sci U S A (1979) 1.72
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol (1996) 1.61
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum (1997) 1.58
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Inotropic therapy for heart failure: an evidence-based approach. Am Heart J (2001) 1.55
Etiology of large pericardial effusions. Am J Med (1993) 1.53
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid (BALF) of COPD horses. Equine Vet J (2001) 1.51
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res (1997) 1.46
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Phosphorylation of intermediate filament proteins by cAMP-dependent protein kinases. Cell (1981) 1.44
Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet (1982) 1.43
The tensor distribution function. Magn Reson Med (2009) 1.43
Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother (1996) 1.40
Diffuse panbronchiolitis: East meets West. Eur Respir J (2007) 1.40
The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes. Proc Natl Acad Sci U S A (2001) 1.40
Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res (1998) 1.39
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2001) 1.38
Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation (1999) 1.36
Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry (1997) 1.35
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35
A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun (1989) 1.35
Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum (2000) 1.31
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo. Oral Dis (2004) 1.31
Volunteerism and Mortality among the Community-dwelling Elderly. J Health Psychol (1999) 1.30
Desmin- and vimentin-containing filaments and their role inthe assembly of the Z disk in muscle cells. Cold Spring Harb Symp Quant Biol (1982) 1.25
Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6. J Biol Chem (2001) 1.23
Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother (1992) 1.23
Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A (2001) 1.22
MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res (2007) 1.21
High prevalence of familial sarcoidosis in an Irish population. Thorax (1984) 1.20
A trypsin-like protease from Bacteroides gingivalis: partial purification and characterization. J Periodontal Res (1987) 1.19
Progesterone induces a rapid increase in [Ca2+]in of Xenopus laevis oocytes. Proc Natl Acad Sci U S A (1980) 1.18
Host-pathogen interactions in progressive chronic periodontitis. J Dent Res (2011) 1.18
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol (2002) 1.17
Kinetic analysis of amino acid pools and protein synthesis in amphibian oocytes and embryos. Dev Biol (1978) 1.16
The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats. J Dent Res (2001) 1.16
Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J Biol Chem (2000) 1.15
Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent (1992) 1.14
The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. J Dent Res (2002) 1.14
Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax (1980) 1.14
The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum (1992) 1.13
Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum (1997) 1.12
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Surface structure, hydrophobicity, phagocytosis, and adherence to matrix proteins of Bacillus cereus cells with and without the crystalline surface protein layer. Infect Immun (1998) 1.12
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol (1997) 1.11
Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics (2001) 1.11
Calcium, potassium, and sodium exchange by full-grown and maturing Xenopus laevis oocytes. Dev Biol (1977) 1.10
Elastin and collagen remodeling in emphysema. A scanning electron microscopy study. Am J Pathol (1996) 1.10
Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax (1988) 1.10
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol (2001) 1.10
Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res (1990) 1.10
Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res (2006) 1.09
A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report. Ann Surg (1993) 1.09
New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol (1998) 1.08
Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol (1999) 1.08
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res (2001) 1.08
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med (1999) 1.07
Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest (1995) 1.07
Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.07
Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Histopathology (2001) 1.07
A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann N Y Acad Sci (1999) 1.06
Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum (1994) 1.06
Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol (1997) 1.05
MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci (1999) 1.05
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail (2003) 1.05